Patent Assignment
Reel/Frame 061601/0001
Security Interest
Recorded: 2022-10-31
Pages: 12
Assignor
PHASEBIO PHARMACEUTICALS, INC.
Executed: 2022-10-28
Assignee
JMB CAPITAL PARTNERS LENDING, LLC
205 SOUTH MARTEL AVENUE, LOS ANGELES, CALIFORNIA, 90036
Covered Properties
(30)
Modified Vasoactive Intestinal Peptides
Application:
15/621,320 →
Publication:
US 2018/0008677
Elp Fusion Proteins Comprising Parathyroid Hormone for Controlled and Sustained Release
Application:
17/633,369 →
Publication:
US 2022/0289812
Formulations of Active Agents for Sustained Release
Application:
14/099,590 →
Publication:
US 2014/0171370
Elp Fusion Proteins for Controlled and Sustained Release
Application:
16/099,261 →
Publication:
US 2019/0218274
Elp Fusion Proteins Comprising Parathyroid Hormone for Controlled and Sustained Release
Application:
62/884,792 →
Metalloenzyme Inhibitor Compounds
Pharmacokinetic & Pharmacodynamic Model for Determining Effective Dose of Anti-Ticagrelor Antibody
Application:
17/739,491 →
Publication:
US 2023/0192895
Metalloenzyme Inhibitor Compounds
Application:
17/350,726 →
Publication:
US 2021/0322409
Methods and Compositions for Treating Cystic Fibrosis
Application:
17/365,443 →
Publication:
US 2022/0023390
Metalloenzyme Inhibitor Compounds
Methods and Compositions for Treating Muscle Disease and Disorders
Application:
17/583,883 →
Publication:
US 2022/0288170
Elp Fusion Proteins for Controlled and Sustained Release
Application:
16/939,624 →
Publication:
US 2020/0353091
Methods of Reversing Ticagrelor Activity
Vasoactive Intestinal Peptide Fusion Proteins for the Treatment of Covid-19
Application:
63/032,244 →
Pharmacokinetic & Pharmacodynamic Model for Determining Effective Dose of Anti-Ticagrelor Antibody
Application:
63/186,515 →
Modified Vasoactive Intestinal Peptides
Modified Vasoactive Intestinal Peptides
Multimeric Elp Fusion Constructs
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
Use of Modified Vasoactive Intestinal Peptides in the Treatment of Hypertension
A Method for Administering a Sustained Release Formulation
Methods and Compositions for Treating Cystic Fibrosis
Elp Fusion Proteins for Controlled and Sustained Release
Methods and Compositions for Treating Muscle Disease and Disorders
Metalloenzyme Inhibitor Compounds
Metalloenzyme Inhibitor Compounds
Metalloenzyme Inhibitor Compounds
Metalloenzyme Inhibitor Compounds
Therapeutic Agents Comprising a Bmp-9 Peptide and Eleastin-Like Peptides
Methods and Compositions for Treating Muscle Disease and Disorders
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2007
From: DAGHER, SUZANNE
To: PHASE BIOSCIENCE, INC.
Reel/Frame 018802/0961 →
Change of Name
Mar 26, 2010
From: PHASE BIOSCIENCE, INC.
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 024143/0049 →
Assignment of Assignor's Interest
Jun 30, 2011
From: SADEGHI, HOMAYOUN; TURNER, ANDREW; DAGHER, SUZANNE
To: PHASBIO PHARMACEUTICALS, INC.
Reel/Frame 026530/0468 →
Assignment of Assignor's Interest
Mar 10, 2014
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0075 →
Assignment of Assignor's Interest
Mar 10, 2014
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 032388/0090 →
Assignment of Assignor's Interest
Nov 23, 2015
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 037117/0277 →
Assignment of Assignor's Interest
Feb 1, 2018
From: ARNOLD, SUSAN; PRIOR, CHRISTOPHER; GEORGOPOULOS, LYNNE
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 044795/0680 →
Assignment of Assignor's Interest
Apr 4, 2018
From: ARNOLD, SUSAN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 045434/0757 →
Assignment of Assignor's Interest
Jun 15, 2018
From: GEORGOPOULOS, LYNNE M.; ARNOLD, SUSAN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046099/0507 →
Assignment of Assignor's Interest
Jun 15, 2018
From: SADEGHI, HOMAYOUN; DAGHER, SUZANNE; TURNER, ANDREW
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 046097/0317 →
Assignment of Assignor's Interest
Apr 4, 2019
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 048796/0907 →
Assignment of Assignor's Interest
Sep 26, 2019
From: BALLANCE, DAVID JAMES; JOWETT, JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 050504/0051 →
Security Interest
Apr 21, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK, AS AGENT
Reel/Frame 052456/0343 →
Assignment of Assignor's Interest
Oct 29, 2020
From: LEE, JOHN; PAUL, SUMITA
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 054206/0524 →
Assignment of Assignor's Interest
Oct 29, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 054206/0431 →
Assignment of Assignor's Interest
Oct 29, 2020
From: JOWETT, JAMES; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 054206/0385 →
Patent and Trademark Security Agreement
Nov 12, 2020
From: PHASEBIO PHARMACEUTICALS, INC.
To: SFJ PHARMACEUTICALS X, LTD.
Reel/Frame 054401/0188 →
Security Interest
Jun 1, 2021
From: PHASEBIO PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 056405/0575 →
Assignment of Assignor's Interest
Jul 8, 2021
From: SELENITY THERAPEUTICS (BERMUDA), LTD.
To: PHASE BIO PHARMACEUTICALS, INC.
Reel/Frame 056794/0957 →
Assignment of Assignor's Interest
Jul 8, 2021
From: SPARKS, STEVEN; YATES, CHRISTOPHER M.
To: SELENITY THERAPEUTICS, LLC
Reel/Frame 056794/0876 →
Assignment of Assignor's Interest
Jul 8, 2021
From: SELENITY THERAPEUTICS, LLC
To: SELENITY THERAPEUTICS (BERMUDA), LTD.
Reel/Frame 056794/0905 →
Assignment of Assignor's Interest
Aug 10, 2021
From: LEE, JOHN; BALLANCE, DAVID JAMES
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 057130/0283 →
Assignment of Assignor's Interest
May 5, 2022
From: LEE, JOHN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 059821/0980 →
Assignment of Assignor's Interest
Aug 30, 2022
From: LEE, JOHN
To: PHASEBIO PHARMACEUTICALS, INC.
Reel/Frame 060941/0887 →
Assignment of Intellectual Property Security Agreement
Oct 4, 2022
From: SILICON VALLEY BANK
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 061606/0035 →